Breaking News

UPM Enhances Pre-Formulation Capabilities

January 8, 2013

Adds TA Instruments

UPM Pharmaceuticals has purchased and qualified a Q20 Auto MDSC (Differential Scanning Calorimeter) and a Q50 TGA (Thermogravimetric Analyzer) by TA Instruments. The equipment enhances the company’s pre-formulation studies, and also supports analytical testing of challenging formulations, including poorly soluble compounds.
UPM’s president, Jim Gregory, said, “UPM sees these new pieces of analytical equipment combined with our already highly qualified and experienced analytical team as a powerful combination for our clients who are trying to make the best and most cost effective decisions about investment of precious research funds. And further is looking for a partner that can perform the latest and best analysis with the most reliable equipment available in the pre-formulation stage of development.”
UPM Pharmaceuticals provides customized formulation development, manufacturing, and analytical services to pharmaceutical, biotechnology, academic, and veterinary clients.
  • U.S. Pharma Market Trends

    Kristin Brooks, Contract Pharma||April 8, 2016
    CPhI Report sees return of generic and API manufacturing to U.S. market

  • DCAT Week ’16 Session Highlights

    Kristin Brooks, Contract Pharma||March 24, 2016
    API and Dose CMO Market Trends and Supply Strategies

  • Talking Trends with Aesica

    Talking Trends with Aesica

    Tim Wright, editor||February 26, 2016
    Managing director Ian Muir fills us in on the latest at the CDMO